Injectable treatments will continue to play a huge role, particularly for people already established on treatment, people who prefer weekly dosing, and those using higher-dose options to maximise weight loss results
Among 169,649 patients with MASLD, GLP-1 receptor agonist initiation was linked to significantly lower probability of incident cirrhosis [adjusted hazard ratio (aHR): 0.86, 95%CI: 0.80-0.93], hepatic decompensation (aHR: 0.77, 95%CI: 0.65-0.90), and hepatocellular carcinoma (HCC) (aHR: 0.79, 95%CI: 0.68-0.92) over a median follow-up of 3.5 years compared to non-users
Youve seen the success stories
The refund language for non-candidates appears more favorable than the general refund policy, so clarify this distinction directly with the company before enrolling
Summer travel (June through September) Summer is the highest-risk season for GLP-1 travel
without glutathione to keep it in line, it initiates oxidative stress in cells, causing damage